
|Articles|July 26, 2018
Linical and Accelovance Merge Under New Linical Name
Advertisement
Linical and Accelovance merged to create a global CRO with a significant footprint across North America, Europe and Asia-Pacific. Under this merger, they will be called Linical and have appointed a new CEO, Vita M. Lanoce. Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2026 DIA Global Annual Meeting: What Drives Sponsors to Mixed Outsourcing Models and What the Transition Looks Like
2
2026 DIA Global Annual Meeting: Why Protocol Digitization Has Been So Hard to Automate—Until Now
3
Tapping the Global Potential of China’s Biotech Surge
4
2026 DIA Global Annual Meeting: How DCT Models Are Changing Recruitment and Retention for Sponsors
5




